Volume | 20,000 |
|
|||||
News | - | ||||||
Day High | 0.097 | Low High |
|||||
Day Low | 0.08555 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
PURE Bioscience Inc (PK) | PURE | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.08555 | 0.08555 | 0.097 | 0.077 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3 | 20,000 | $ 0.096771 | $ 1,935 | - | 0.063 - 0.167 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:17:11 | 9,800 | $ 0.097 | USD |
PURE Bioscience Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.19M | 111.86M | 66.38M | 1.88M | -3.96M | -0.04 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
PURE Bioscience (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PURE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.073 | 0.098 | 0.073 | 0.0865979 | 14,212 | 0.024 | 32.88% |
1 Month | 0.08 | 0.0989 | 0.067 | 0.0841943 | 14,582 | 0.017 | 21.25% |
3 Months | 0.0997 | 0.1134 | 0.063 | 0.0844621 | 24,765 | -0.0027 | -2.71% |
6 Months | 0.106 | 0.167 | 0.063 | 0.1110118 | 35,030 | -0.009 | -8.49% |
1 Year | 0.12 | 0.167 | 0.063 | 0.1088771 | 33,907 | -0.023 | -19.17% |
3 Years | 0.55 | 0.55 | 0.063 | 0.1989188 | 45,521 | -0.453 | -82.36% |
5 Years | 0.40 | 2.05 | 0.063 | 0.6180902 | 62,442 | -0.303 | -75.75% |
PURE Bioscience (PK) Description
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. Additional information on PURE is available at www.purebio.com |